{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:20:01Z","timestamp":1788967201687,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s42000-021-00316-z","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T18:53:22Z","timestamp":1630695202000},"page":"147-154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cushing\u2019s syndrome due to adrenocorticotropic hormone-secreting metastatic neuroendocrine tumor of unknown primary origin: a case report and literature review"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4957-9856","authenticated-orcid":false,"given":"Hayri","family":"Bostan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Duger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Akhanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Calapkulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba Taskin","family":"Turkmenoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Kevser","family":"Erdol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap Akcali","family":"Duru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Erkam","family":"Sencar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Kizilgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekir","family":"Ucan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erman","family":"Cakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"316_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015) Cushing\u2019s syndrome. Lancet 386:913\u2013927. https:\/\/doi.org\/10.1016\/S0140-6736(14)61375-1","journal-title":"Lancet"},{"key":"316_CR2","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1530\/EJE-19-0877","volume":"182","author":"J Young","year":"2020","unstructured":"Young J, Haissaguerre M, Viera-Pinto O, Chabre O, Baudin E, Tabarin A (2020) Management of endocrine disease: Cushing\u2019s syndrome due to ectopic ACTH secretion: an expert operational opinion. Eur J Endocrinol 182:R29\u2013R58. https:\/\/doi.org\/10.1530\/EJE-19-0877","journal-title":"Eur J Endocrinol"},{"key":"316_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel M, Costa F, Capdevila J, Gross D, Kianmanesh R, Krenning E et al (2016) ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology 103:172\u2013185. https:\/\/doi.org\/10.1159\/000443167","journal-title":"Neuroendocrinology"},{"key":"316_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s42000-019-00163-z","volume":"19","author":"I Lase","year":"2020","unstructured":"Lase I, Strele I, Gr\u00f6nberg M, Kozlovacki G, Welin S, Janson ET (2020) Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing\u2019s syndrome. Hormones (Athens) 19:351\u2013360. https:\/\/doi.org\/10.1007\/s42000-019-00163-z","journal-title":"Hormones (Athens)"},{"key":"316_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1530\/EJE-15-0968","volume":"174","author":"K Kamp","year":"2016","unstructured":"Kamp K, Alwani RA, Korpershoek E, Franssen GJH, de Herder WW, Feelders RA (2016) Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors. Eur J Endocrinol 174:271\u2013280. https:\/\/doi.org\/10.1530\/EJE-15-0968","journal-title":"Eur J Endocrinol"},{"key":"316_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1210\/er.2003-0014","volume":"25","author":"GA Kaltsas","year":"2004","unstructured":"Kaltsas GA, Besser GM, Grossman AB (2004) The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 25:458\u2013511. https:\/\/doi.org\/10.1210\/er.2003-0014","journal-title":"Endocr Rev"},{"key":"316_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11154-017-9437-9","volume":"18","author":"K Alexandraki","year":"2017","unstructured":"Alexandraki K, Angelousi A, Boutzios G, Kyriakopoulos G, Rontogianni D, Kaltsas G (2017) Management of neuroendocrine tumors of unknown primary. Rev Endocr Metab Disord 18:423\u2013431. https:\/\/doi.org\/10.1007\/s11154-017-9437-9","journal-title":"Rev Endocr Metab Disord"},{"key":"316_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3978\/j.issn.2304-3865.2016.02.03","volume":"5","author":"Y-Z Wang","year":"2016","unstructured":"Wang Y-Z, Chauhan A, Rau J, Diebold AE, Opoku-Boateng A, Ramcharan T et al (2016) Neuroendocrine tumors (NETs) of unknown primary: is early surgical exploration and aggressive debulking justifiable? Chin Clin Oncol 5:4. https:\/\/doi.org\/10.3978\/j.issn.2304-3865.2016.02.03","journal-title":"Chin Clin Oncol"},{"key":"316_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/archsurg.2010.10","volume":"145","author":"SC Wang","year":"2010","unstructured":"Wang SC, Parekh JR, Zuraek MB et al (2010) Identification of unknown primary tumors in patients with neuroendocrine liver metastases. Arch Surg 145:276\u2013280. https:\/\/doi.org\/10.1001\/archsurg.2010.10","journal-title":"Arch Surg"},{"key":"316_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00330-012-2615-y","volume":"23","author":"P Bhosale","year":"2013","unstructured":"Bhosale P, Shah A, Wei W et al (2013) Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases. Eur Radiol 23:400\u2013407. https:\/\/doi.org\/10.1007\/s00330-012-2615-y","journal-title":"Eur Radiol"},{"key":"316_CR11","doi-asserted-by":"publisher","first-page":"160018","DOI":"10.1530\/EDM-16-0018","volume":"2016","author":"MJ Trott","year":"2016","unstructured":"Trott MJ, Farah G, Stokes VJ, Wang LM, Grossman AB (2016) A thymic neuroendocrine tumour in a young female: a rare cause of relapsing and remitting Cushing\u2019s syndrome. Endocrinol Diabetes Metab Case Rep 2016:160018. https:\/\/doi.org\/10.1530\/EDM-16-0018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"316_CR12","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM199109263251301","volume":"325","author":"EH Oldfield","year":"1991","unstructured":"Oldfield EH, Doppman JL, Nieman LK et al (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing\u2019s syndrome. N Engl J Med 325:897\u2013905. https:\/\/doi.org\/10.1056\/NEJM199109263251301","journal-title":"N Engl J Med"},{"key":"316_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00330-008-1274-5","volume":"19","author":"PA Sookur","year":"2009","unstructured":"Sookur PA, Sahdev A, Rockall AG et al (2009) Imaging in covert ectopic ACTH secretion: a CT pictorial review. Eur Radiol 19:1069\u20131078. https:\/\/doi.org\/10.1007\/s00330-008-1274-5","journal-title":"Eur Radiol"},{"key":"316_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1210\/jc.2009-2282","volume":"95","author":"MS Zemskova","year":"2010","unstructured":"Zemskova MS, Gundabolu B, Sinaii N et al (2010) Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab 95:1207\u20131219. https:\/\/doi.org\/10.1210\/jc.2009-2282","journal-title":"J Clin Endocrinol Metab"},{"key":"316_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/cen.13745","volume":"89","author":"S Gabriel","year":"2018","unstructured":"Gabriel S, Garrigue P, Dahan L et al (2018) Prospective evaluation of 68Ga-DOTATATE PET\/CT in limited disease neuroendocrine tumours and\/or elevated serum neuroendocrine biomarkers. Clin Endocrinol (Oxf) 89:155\u2013163. https:\/\/doi.org\/10.1111\/cen.13745","journal-title":"Clin Endocrinol (Oxf)"},{"key":"316_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/RLU.0b013e318279f0f5","volume":"38","author":"W Moore","year":"2013","unstructured":"Moore W, Freiberg E, Bishawi M et al (2013) FDG-PET imaging in patients with pulmonary carcinoid tumor. Clin Nucl Med 38:501\u2013505. https:\/\/doi.org\/10.1097\/RLU.0b013e318279f0f5","journal-title":"Clin Nucl Med"},{"key":"316_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2967\/jnumed.116.178095","volume":"58","author":"E Panagiotidis","year":"2017","unstructured":"Panagiotidis E, Alshammari A, Michopoulou S et al (2017) Comparison of the impact of 68Ga-DOTATATE and 18F-FDG PET\/CT on clinical management in patients with neuroendocrine tumors. J Nucl Med 58:91\u201396. https:\/\/doi.org\/10.2967\/jnumed.116.178095","journal-title":"J Nucl Med"},{"key":"316_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF01665863","volume":"69","author":"E Kornely","year":"1991","unstructured":"Kornely E, Schlaghecke R, Horster FA (1991) Palliative therapy of an ectopic cushing\u2019s syndrome due to a metastatic carcinoid tumor. Klin Wochenschr 69:173\u2013176. https:\/\/doi.org\/10.1007\/BF01665863","journal-title":"Klin Wochenschr"},{"key":"316_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s0748-7983(98)80022-x","volume":"24","author":"H Takami","year":"1998","unstructured":"Takami H, Ogino Y, Tanaka K, Kubo A (1998) Somatostatin-receptor-negative carcinoid tumour responsible for Cushing\u2019s syndrome. Eur J Surg Oncol 24:337\u2013338. https:\/\/doi.org\/10.1016\/s0748-7983(98)80022-x","journal-title":"Eur J Surg Oncol"},{"key":"316_CR20","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s00268-001-0032-5","volume":"25","author":"JP Aniszewski","year":"2001","unstructured":"Aniszewski JP, Young WF Jr, Thompson GB, Grant CS, van Heerden JA (2001) Cushing syndrome doe to ectopic adrenocorticotropic hormone secretion. World J Surg 25:934\u2013940. https:\/\/doi.org\/10.1007\/s00268-001-0032-5","journal-title":"World J Surg"},{"key":"316_CR21","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1210\/jc.2004-2527","volume":"90","author":"I Ilias","year":"2005","unstructured":"Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK (2005) Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health. J Clin Endocrinol Metab 90:4955\u20134962. https:\/\/doi.org\/10.1210\/jc.2004-2527","journal-title":"J Clin Endocrinol Metab"},{"key":"316_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1210\/jc.2005-1542","volume":"91","author":"AM Isidori","year":"2006","unstructured":"Isidori AM, Kaltsas GA, Pozza C et al (2006) The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 91:371\u2013377. https:\/\/doi.org\/10.1210\/jc.2005-1542","journal-title":"J Clin Endocrinol Metab"},{"key":"316_CR23","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1002\/cncr.26029","volume":"117","author":"S Ejaz","year":"2011","unstructured":"Ejaz S, Vassilopoulou-Sellin R, Busaidy NL et al (2011) Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer 117:4381\u20134389. https:\/\/doi.org\/10.1002\/cncr.26029","journal-title":"Cancer"},{"key":"316_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12020-018-1773-3","volume":"64","author":"K Daskalakis","year":"2019","unstructured":"Daskalakis K, Chatzelis E, Tsoli M et al (2019) Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms. Endocrine 64:384\u2013392. https:\/\/doi.org\/10.1007\/s12020-018-1773-3","journal-title":"Endocrine"},{"key":"316_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12902-019-0433-9","volume":"19","author":"A Albani","year":"2019","unstructured":"Albani A, Berr CM, Beuschlein F et al (2019) A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing\u2019s syndrome. BMC Endocr Disord 19:105. https:\/\/doi.org\/10.1186\/s12902-019-0433-9","journal-title":"BMC Endocr Disord"},{"key":"316_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/cen.14008","volume":"91","author":"T Wannachalee","year":"2019","unstructured":"Wannachalee T, Turcu AF, Bancos I et al (2019) The clinical impact of [68Ga]-DOTATATE PET\/CT for the diagnosis and management of ectopic adrenocorticotropic hormone\u2013secreting tumours. Clin Endocrinol (Oxf) 91:288\u2013294. https:\/\/doi.org\/10.1111\/cen.14008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"316_CR27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/annonc\/mdv041","volume":"26","author":"ME Caplin","year":"2015","unstructured":"Caplin ME, Baudin E, Ferolla P et al (2015) Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol 26:1604\u20131620. https:\/\/doi.org\/10.1093\/annonc\/mdv041","journal-title":"Ann Oncol"},{"key":"316_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.anndiagpath.2017.04.00","volume":"29","author":"JY Kim","year":"2017","unstructured":"Kim JY, Hong S-M, Ro JY (2017) Recent updates on grading and classification of neuroendocrine tumors. Ann Diagn Pathol 29:11\u201316. https:\/\/doi.org\/10.1016\/j.anndiagpath.2017.04.00","journal-title":"Ann Diagn Pathol"},{"key":"316_CR29","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1210\/jc.2015-2616","volume":"100","author":"E Daniel","year":"2015","unstructured":"Daniel E, Aylwin S, Mustafa O et al (2015) Effectiveness of metyrapone in treating Cushing\u2019s syndrome: a retrospective multicenter study in 195 patients. J Clin Endocrinol Metab 100:4146\u20134154. https:\/\/doi.org\/10.1210\/jc.2015-2616","journal-title":"J Clin Endocrinol Metab"},{"key":"316_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1530\/EJE-14-0913","volume":"172","author":"J-B Corcuff","year":"2015","unstructured":"Corcuff J-B, Young J, Masquefa-Giraud P, Chanson P, Baudin E, Tabarin A (2015) Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole. Eur J Endocrinol 172:473\u2013481. https:\/\/doi.org\/10.1530\/EJE-14-0913","journal-title":"Eur J Endocrinol"},{"key":"316_CR31","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","volume":"27","author":"A Rinke","year":"2009","unstructured":"Rinke A, Muller HH, Schade-Brittinger C et al (2009) Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 27:4656\u20134663. https:\/\/doi.org\/10.1200\/JCO.2009.22.8510","journal-title":"J Clin Oncol"},{"key":"316_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1530\/ERC-15-0490","volume":"23","author":"ME Caplin","year":"2016","unstructured":"Caplin ME, Pavel M, \u0106wik\u0142a JB et al (2016) Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study. Endocr Relat Cancer 23:191\u2013199. https:\/\/doi.org\/10.1530\/ERC-15-0490","journal-title":"Endocr Relat Cancer"},{"key":"316_CR33","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1634\/theoncologist.2019-0361","volume":"25","author":"T Al-Toubah","year":"2020","unstructured":"Al-Toubah T, Morse B, Strosberg J (2020) Capecitabine and temozolomide in advanced lung neuroendocrine neoplasms. Oncologist 25:e48\u2013e52. https:\/\/doi.org\/10.1634\/theoncologist.2019-0361","journal-title":"Oncologist"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-021-00316-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:03:46Z","timestamp":1744193026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-021-00316-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1007\/s42000-021-00316-z","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"15 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient before the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was provided from the patient for publication of this case report and accompanying images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}